Internal Medicine, Nephrology · Cranberry, PA
NPI
1649214552
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
6945 US 322 Unit 508
Cranberry, PA, 16319
Phone (814) 678-1177
Groups this clinician bills Medicare through
Medicare paid, 2024
$136K
1,521 services
Medicare patients, 2024
366
Average age 74
Drug cost, 2024
$1.3M
1,839 prescriptions
Company payments, 2025
$106
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David R Brooker was code 99214 (office e&m - established), 332 times for 172 patients. In total David R Brooker billed 1,521 services in 29 codes, and Medicare paid $136K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-04-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 332 | 172 | $84.38 | $28K |
| 90960 ESRD Related Services (not dialysis) | Office | 184 | 28 | $258.68 | $48K |
| 99232 Hospital E&M - Subsequent | Facility | 175 | 54 | $59.44 | $10K |
| 99213 Office E&M - Established | Office | 174 | 130 | $60.57 | $11K |
| 99231 Hospital E&M - Subsequent | Facility | 123 | 47 | $37.43 | $4,603 |
| 99222 Hospital E&M - Initial | Facility | 69 | 60 | $95.25 | $6,572 |
| 99204 Office E&M - New | Office | 57 | 57 | $102.31 | $5,832 |
| 99221 Hospital E&M - Initial | Facility | 27 | 23 | $58.32 | $1,575 |
By year: 2022 $182K for 1,933 services; 2023 $166K for 1,875 services; 2024 $136K for 1,521 services.
Medicare prescription drug claims, 2024
In 2024, the drug David R Brooker prescribed most often to Medicare patients was Farxiga (Dapagliflozin Propanediol), with 229 prescriptions and refills. In total David R Brooker wrote 1,839 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Farxiga Dapagliflozin Propanediol | 229 | 364 | 67 | $197K |
| Valsartan Generic | 170 | 491 | 55 | $6,198 |
| Calcitriol Generic | 152 | 379 | 48 | $2,256 |
| Paricalcitol Generic | 80 | 186 | 28 | $8,408 |
| Kerendia Finerenone | 71 | 127 | 23 | $80K |
| Lisinopril Generic | 68 | 156 | 22 | $404 |
| Allopurinol Generic | 66 | 166 | 16 | $618 |
| Chlorthalidone Generic | 65 | 195 | 18 | $1,662 |
| Torsemide Generic | 64 | 123 | 23 | $1,428 |
| Amlodipine Besylate Generic | 62 | 154 | 22 | $454 |
| Rayaldee Calcifediol | 62 | 70 | Under 11 | $86K |
| Losartan Potassium Generic | 52 | 140 | 17 | $729 |
| Furosemide Generic | 40 | 109 | 17 | $250 |
| Jynarque Tolvaptan | 31 | 31 | Under 11 | $627K |
| Veltassa Patiromer Calcium Sorbitex | 31 | 46 | Under 11 | $34K |
Brand drugs: 508 claims; generic drugs: 1,331 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David R Brooker $106 ($106 in general payments such as food, travel and fees) from 4 companies. The largest payer was Otsuka America Pharmaceutical, Inc. with $44.87.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.